Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

20 October 2022

Indonesiƫ verbiedt verkoop mogelijk giftige hoestsiroop na dood 99 kinderen

Direct links

Read the article

In an article for the Dutch de Volkskrant, the Foundation's Research Programme Manager,Ā Claudia MartĆ­nez, speaks about the vulnerable position of low- and middle-income countries in the global medication chain.Ā 

"Veel arme landen hebben de expertise en capaciteit niet om te controleren welke medicijnen het land binnenkomen. Of ze beschikken niet over de juiste laboratoria om te blijven testen en monitoren."

The article discusses the temporary ban on the sale of potentially toxic cough syrup in Indonesia following the death of 99 children.Ā Earlier in the month, 70 children in The Gambia died after ingesting a syrup containing high doses of diethylene glycol and ethylene glycol. The Indonesian authorities are working with the World Health Organization (WHO) to find out how the drugs came on the market and whether there is a link with the drugs that caused the deaths of children in The Gambia.

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved